Menorrhagia. ??????? ???? ?????? ?? ??????? ????.
Conditions
Interventions
Intervention 1: mefenamic acid cap 500 mg q8hr and Urtica dioica cap 1 mg q12hr, from the first day of menstrustion, for 7 days will be prescribed to intervention group. Intervention 2: mefenamic acid
Treatment - Drugs
mefenamic acid cap 500 mg q8hr and Urtica dioica cap 1 mg q12hr, from the first day of menstrustion, for 7 days will be prescribed to intervention group.
mefenamic acid cap 500 mg q8hr and placebo of Urtica dioica cap 1 mg q12hr, from the first day of menstrustion, for 7 days will be prescribed to placebo group.
Sponsors
International part Of Shahid Beheshti University of Medical Science
Eligibility
Sex/Gender
Female
Age
15 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Age15 to 45 years; Body Mass Index 18.5 to 29.9; Being affected by menorrhagia, distinguished by using pictorial blood loss assessment chart. exclusion criteria: Having an special disease; pregnancy or deciding to be pregnant in three future month; berestfeeding; allergy to urtica dioica; dont follow the exact priscribed curing method; patient,s tendency to going out of study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of days of bleeding in menstruation. Timepoint: Befor, one month and then two month after intervention. Method of measurement: By using pictorial blood loss assessmant chart.;Amount of menstrual Bleeding. Timepoint: Befor, one month and two month after intervention. Method of measurement: By using pictorial blood loss assessmant chart. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects of priscribed drugs. Timepoint: During and after first and second month of using drugs. Method of measurement: By using the chart of daily using of drugs. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAtefe Sourtiji
International Part Of Shahid Beheshti University of Medical Science
Outcome results
None listed